- call +1-201-465-4211
- email sales@mrinsights.biz
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.
Scope of the Report:
This report focuses on the Erythropoietin Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.
The worldwide market for Erythropoietin Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
F. Hoffmann-La Roche
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Hospira
Boehringer Ingelheim
LG Life Science
Novartis
Pfizer
Daichi Sankyo
Biocon
Chugai Pharmaceutical
Teva Pharmaceutical Industries
Wanbang Biochemical Pharmaceuticals
Ahua Pharmaceutical
Huaxin High Biotechnology
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Natural Erythropoietin
Non-natural Erythropoietin
Market Segment by Applications, can be divided into
Hospitals
Retail Pharmacies
Others
There are 15 Chapters to deeply display the global Erythropoietin Drugs market.
Chapter 1, to describe Erythropoietin Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Erythropoietin Drugs, with sales, revenue, and price of Erythropoietin Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Erythropoietin Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Erythropoietin Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Erythropoietin Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Erythropoietin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Natural Erythropoietin
1.2.2 Non-natural Erythropoietin
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Retail Pharmacies
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Erythropoietin Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Erythropoietin Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Erythropoietin Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Kyowa Hakko Kirin
2.4.1 Business Overview
2.4.2 Erythropoietin Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hospira
2.5.1 Business Overview
2.5.2 Erythropoietin Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hospira Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Erythropoietin Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 LG Life Science
2.7.1 Business Overview
2.7.2 Erythropoietin Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LG Life Science Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Erythropoietin Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Erythropoietin Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Daichi Sankyo
2.10.1 Business Overview
2.10.2 Erythropoietin Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Daichi Sankyo Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biocon
2.11.1 Business Overview
2.11.2 Erythropoietin Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocon Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Chugai Pharmaceutical
2.12.1 Business Overview
2.12.2 Erythropoietin Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Chugai Pharmaceutical Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Teva Pharmaceutical Industries
2.13.1 Business Overview
2.13.2 Erythropoietin Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Teva Pharmaceutical Industries Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Wanbang Biochemical Pharmaceuticals
2.14.1 Business Overview
2.14.2 Erythropoietin Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Wanbang Biochemical Pharmaceuticals Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ahua Pharmaceutical
2.15.1 Business Overview
2.15.2 Erythropoietin Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ahua Pharmaceutical Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Huaxin High Biotechnology
2.16.1 Business Overview
2.16.2 Erythropoietin Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Huaxin High Biotechnology Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Erythropoietin Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Erythropoietin Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Erythropoietin Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Erythropoietin Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Erythropoietin Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Erythropoietin Drugs Market Analysis by Regions
4.1 Global Erythropoietin Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Erythropoietin Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Erythropoietin Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Erythropoietin Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Erythropoietin Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Erythropoietin Drugs Sales and Growth Rate (2013-2018)
4.5 South America Erythropoietin Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Erythropoietin Drugs Sales and Growth Rate (2013-2018)
5 North America Erythropoietin Drugs by Countries
5.1 North America Erythropoietin Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Erythropoietin Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Erythropoietin Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Erythropoietin Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Erythropoietin Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Erythropoietin Drugs Sales and Growth Rate (2013-2018)
6 Europe Erythropoietin Drugs by Countries
6.1 Europe Erythropoietin Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Erythropoietin Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Erythropoietin Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Erythropoietin Drugs Sales and Growth Rate (2013-2018)
6.3 UK Erythropoietin Drugs Sales and Growth Rate (2013-2018)
6.4 France Erythropoietin Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Erythropoietin Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Erythropoietin Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Erythropoietin Drugs by Countries
7.1 Asia-Pacific Erythropoietin Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Erythropoietin Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Erythropoietin Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Erythropoietin Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Erythropoietin Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Erythropoietin Drugs Sales and Growth Rate (2013-2018)
7.5 India Erythropoietin Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Erythropoietin Drugs Sales and Growth Rate (2013-2018)
8 South America Erythropoietin Drugs by Countries
8.1 South America Erythropoietin Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Erythropoietin Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Erythropoietin Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Erythropoietin Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Erythropoietin Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Erythropoietin Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Erythropoietin Drugs by Countries
9.1 Middle East and Africa Erythropoietin Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Erythropoietin Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Erythropoietin Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Erythropoietin Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Erythropoietin Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Erythropoietin Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Erythropoietin Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Erythropoietin Drugs Sales and Growth Rate (2013-2018)
10 Global Erythropoietin Drugs Market Segment by Type
10.1 Global Erythropoietin Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Erythropoietin Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Erythropoietin Drugs Revenue and Market Share by Type (2013-2018)
10.2 Natural Erythropoietin Sales Growth and Price
10.2.1 Global Natural Erythropoietin Sales Growth (2013-2018)
10.2.2 Global Natural Erythropoietin Price (2013-2018)
10.3 Non-natural Erythropoietin Sales Growth and Price
10.3.1 Global Non-natural Erythropoietin Sales Growth (2013-2018)
10.3.2 Global Non-natural Erythropoietin Price (2013-2018)
11 Global Erythropoietin Drugs Market Segment by Application
11.1 Global Erythropoietin Drugs Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Erythropoietin Drugs Market Forecast (2018-2023)
12.1 Global Erythropoietin Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Erythropoietin Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Erythropoietin Drugs Market Forecast (2018-2023)
12.2.2 Europe Erythropoietin Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Erythropoietin Drugs Market Forecast (2018-2023)
12.2.4 South America Erythropoietin Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Erythropoietin Drugs Market Forecast (2018-2023)
12.3 Erythropoietin Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Erythropoietin Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Erythropoietin Drugs Market Share Forecast by Type (2018-2023)
12.4 Erythropoietin Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Erythropoietin Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Erythropoietin Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Erythropoietin Drugs Picture
Table Product Specifications of Erythropoietin Drugs
Figure Global Sales Market Share of Erythropoietin Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
